Search for: "ALLEN v. WARNER" Results 1 - 20 of 57
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Apr 2024, 2:31 am by INFORRM
On Thursday 18 April 2024 there will be an application for permission in relation to a committal in HM Solicitor General v Warner KB-2023-004710. [read post]
31 Jul 2023, 2:23 am by INFORRM
On Thursday 27 July 2023 there were hearings in the libel cases of Jusan Technologies Ltd v. (1) The Bureau of Investigative Journalism (2) Telegraph Media Group Ltd  and  Jusan Technologies Ltd v. [read post]
2 Feb 2023, 6:30 am by John Mikhail
In addition, Wilson was one of the main authors of the 1790 Pennsylvania constitution—another surprisingly neglected fact about him, which bears on Moore v. [read post]
27 Nov 2022, 4:38 pm by INFORRM
On 21 November 2022, judgment was handed down in Marks v Allen, 2022 BCSC 2024. [read post]
1 Aug 2022, 12:11 pm by INFORRM
On 28 July 2022, there were hearings in ABC and Others v London Borough of Lambeth and SJU and Others v London Borough of Lambeth before Nicklin J and in Nicolaisen v Nicolaisen before Jay J. [read post]
9 Feb 2019, 2:13 am
| The IP term (thus far) of the millennium: the curious story of the adoption of "patent troll" and "internet trolling" | No pain, no gain: Plausibility in Warner-Lambert v Actavis | Testing the boundaries of subjectivity: Infringement of Swiss-type claims in Warner-Lambert v Actavis | Is SPINNING generic? [read post]
2 Oct 2018, 1:00 pm by Guest Blogger
On appeal, also based on a review of physical similarities and the totality of attributes and traits, the lower court finding was upheld (Warner Bros., Inc., v. [read post]
17 Jun 2018, 4:16 pm by INFORRM
AT&T has acquired Time Warner for $85 billion following the approval of Judge Richard Leon this Tuesday. [read post]
31 Mar 2018, 8:30 am
DesignsKat friend Natasha Rao (Allen & Overy) provides an Event Report on this year's INTA Designs conference: Event Report: INTA Designs Conference 2018. [read post]
5 Apr 2016, 6:32 am
 A third case to watch out for is Novartis's Aclasta (zoledronic acid) patent with Swiss-type claims for the use of zoledronic acid in a once-yearly i/v administration for the treatment of osteoporosis. [read post]
17 Jul 2015, 10:17 am by Mary Jane Wilmoth
KokeshCase Number: 09-cv-01021 (United States District Court for the District of New Mexico)Case Filed: October 27, 2009Qualifying Judgment/Order: March 30, 2015 4/30/15 7/29/15 2015-39 SEC v. [read post]